This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The Toronto Leukaemia Study Group . Results of chemotherapy for unselected patients with acute myeloblastic leukaemia: effect of exclusions on interpretation of results Lancet 1986 i: 786–788
Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS . Underrepresentation of patients 65 years of age or older in cancer-treatment trials New Engl J Med 1999 341: 2061–2067
Proctor SJ, Taylor PRA . A practical guide to population-based data collection (PACE): a process facilitating uniformity of care and research into practice QJM 2000 93: 67–73
Burnett AK, Goldstone AH, Stevens RMF, Hann IM, Rees JKH, Gray RG, Wheatley K, for the UK Medical Research Council Adult and Children's Leukaemia Working Parties . Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial Lancet 1998 351: 700–708
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A . The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial Blood 1998 92: 2322–2333
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Proctor, S., Taylor, P. Age cohort subgroups in adult acute myeloid leukaemia studies - the population perspective. Leukemia 15, 188–189 (2001). https://doi.org/10.1038/sj.leu.2401972
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401972